Cathay Long Term Debt vs Non Currrent Assets Other Analysis

688065 Stock   42.02  0.48  1.13%   
Cathay Biotech financial indicator trend analysis is way more than just evaluating Cathay Biotech prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cathay Biotech is a good investment. Please check the relationship between Cathay Biotech Long Term Debt and its Non Currrent Assets Other accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Long Term Debt vs Non Currrent Assets Other

Long Term Debt vs Non Currrent Assets Other Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cathay Biotech Long Term Debt account and Non Currrent Assets Other. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Cathay Biotech's Long Term Debt and Non Currrent Assets Other is 0.83. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Non Currrent Assets Other in the same time period over historical financial statements of Cathay Biotech, assuming nothing else is changed. The correlation between historical values of Cathay Biotech's Long Term Debt and Non Currrent Assets Other is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Cathay Biotech are associated (or correlated) with its Non Currrent Assets Other. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Currrent Assets Other has no effect on the direction of Long Term Debt i.e., Cathay Biotech's Long Term Debt and Non Currrent Assets Other go up and down completely randomly.

Correlation Coefficient

0.83
Relationship DirectionPositive 
Relationship StrengthStrong

Long Term Debt

Long-term debt is a debt that Cathay Biotech has held for over one year. Long-term debt appears on Cathay Biotech balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Cathay Biotech balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Non Currrent Assets Other

Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.
Most indicators from Cathay Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cathay Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cathay Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
The current year's Tax Provision is expected to grow to about 56.8 M, whereas Selling General Administrative is forecasted to decline to about 83.2 M.
 2021 2022 2023 2024 (projected)
Interest Expense16.3M20.0M32.2M19.7M
Interest Income213.3M236.8M219.8M156.9M

Cathay Biotech fundamental ratios Correlations

-0.930.640.980.980.380.920.880.930.770.880.91-0.820.670.91-0.740.730.990.740.920.910.830.940.810.82
-0.93-0.41-0.98-0.86-0.05-0.97-0.67-0.9-0.93-0.83-0.920.62-0.54-0.730.72-0.43-0.96-0.64-0.98-0.75-0.96-0.82-0.57-0.58
0.64-0.410.550.720.710.430.770.480.070.480.67-0.750.430.71-0.370.820.610.860.430.750.260.620.840.84
0.98-0.980.550.940.230.950.790.910.850.830.94-0.70.580.81-0.70.591.00.740.960.840.90.860.710.72
0.98-0.860.720.940.540.840.950.910.660.860.87-0.830.710.94-0.710.830.970.760.840.960.720.920.90.91
0.38-0.050.710.230.540.00.760.29-0.230.310.19-0.490.550.6-0.20.890.310.410.00.67-0.190.380.850.84
0.92-0.970.430.950.840.00.640.870.90.80.89-0.710.460.74-0.680.430.940.651.00.690.970.870.530.54
0.88-0.670.770.790.950.760.640.820.440.810.71-0.820.790.95-0.660.950.840.670.640.980.480.850.980.99
0.93-0.90.480.910.910.290.870.820.830.990.83-0.790.840.91-0.920.640.920.50.860.890.810.910.720.73
0.77-0.930.070.850.66-0.230.90.440.830.760.76-0.430.470.56-0.710.160.810.350.910.540.960.680.290.3
0.88-0.830.480.830.860.310.80.810.990.760.78-0.810.90.92-0.970.640.850.420.790.880.740.910.70.71
0.91-0.920.670.940.870.190.890.710.830.760.78-0.70.520.75-0.690.520.930.830.910.80.860.790.660.67
-0.820.62-0.75-0.7-0.83-0.49-0.71-0.82-0.79-0.43-0.81-0.7-0.68-0.930.73-0.8-0.75-0.6-0.68-0.8-0.56-0.95-0.76-0.77
0.67-0.540.430.580.710.550.460.790.840.470.90.52-0.680.86-0.90.70.620.20.460.850.380.720.730.73
0.91-0.730.710.810.940.60.740.950.910.560.920.75-0.930.86-0.830.880.860.590.720.950.60.950.890.9
-0.740.72-0.37-0.7-0.71-0.2-0.68-0.66-0.92-0.71-0.97-0.690.73-0.9-0.83-0.49-0.71-0.26-0.68-0.76-0.67-0.8-0.55-0.56
0.73-0.430.820.590.830.890.430.950.640.160.640.52-0.80.70.88-0.490.660.610.420.880.230.750.970.97
0.99-0.960.611.00.970.310.940.840.920.810.850.93-0.750.620.86-0.710.660.760.940.880.870.890.770.78
0.74-0.640.860.740.760.410.650.670.50.350.420.83-0.60.20.59-0.260.610.760.670.670.550.60.710.71
0.92-0.980.430.960.840.01.00.640.860.910.790.91-0.680.460.72-0.680.420.940.670.690.980.850.530.54
0.91-0.750.750.840.960.670.690.980.890.540.880.8-0.80.850.95-0.760.880.880.670.690.570.850.950.95
0.83-0.960.260.90.72-0.190.970.480.810.960.740.86-0.560.380.6-0.670.230.870.550.980.570.760.360.37
0.94-0.820.620.860.920.380.870.850.910.680.910.79-0.950.720.95-0.80.750.890.60.850.850.760.760.77
0.81-0.570.840.710.90.850.530.980.720.290.70.66-0.760.730.89-0.550.970.770.710.530.950.360.761.0
0.82-0.580.840.720.910.840.540.990.730.30.710.67-0.770.730.9-0.560.970.780.710.540.950.370.771.0
Click cells to compare fundamentals

Cathay Biotech Account Relationship Matchups

Currently Active Assets on Macroaxis

Other Information on Investing in Cathay Stock

Balance Sheet is a snapshot of the financial position of Cathay Biotech at a specified time, usually calculated after every quarter, six months, or one year. Cathay Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Cathay Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Cathay currently owns. An asset can also be divided into two categories, current and non-current.